Femme et Homme
- | Pays :
- France
- Ukraine
- Hungary
- Les 9 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to compare progression free survival for SU011248 [sutent (sunitinib malate)] versus standard of care therapy in patients with previously treated, advanced, triple receptor negative (ER, PR, HER2) locally recurrent or metastatic breast cancer.
Critère d'inclusion
- Breast Neoplasms